What You Will Discover at Our Interactive Station

• RetinAI OCT Atlas^®: Explore our CE-marked dual-processor engine. By unifying Layer and Fluid Segmentation into a single automated pipeline, it delivers deeper structural insights across multiple retinal pathologies, ranging from diabetic retinopathy (DR/DME) and glaucoma to the full spectrum of age-related macular degeneration (early, intermediate, nAMD, and GA).
• LuxIA^® Screening: Live demonstration of our fast-screening solution designed to detect more-than-mild diabetic retinopathy (mtmDR) directly from color fundus photographs.
• Smart Workflow Integrations: Hands-on view of how AI analytics integrate into daily clinical imaging routines to reduce manual workload.
• Seamless Heidelberg Connectivity via Discovery CONNECT^®: Experience live data transfer showing how OCT scans captured on Heidelberg Engineering’s SPECTRALIS^® and the new R1 are instantly synced to RetinAI Discovery^® for immediate automated segmentation and AI biomarker analysis.

Book a 1:1 Demo at EIS & EURETINA

‍

Exclusive Evening Event: “Finding the Right Patient: AI-Powered Clinical Trial Recruitment”

Thursday, 1 October 2026 | 5:15 PM – 8 PM I Prisma by Lumia

Join us for an evening of in-depth discussion and interactive case reviews from our esteemed faculty members consisting of (in alphabetical order) Drs. Aude Ambresin, Laurentino Biccas, Omer Trivizki, Patricia Udaondo and Stela Vujosevic.

Through expert panel discussions, real-world case challenges, and an interactive "Human vs. AI" session, discover how RetinAI’s advanced imaging and data analytics increase screening precision, accelerate candidate identification, and reduce trial recruitment burden.

Reserve Your Spot Now - Limited Capacity

‍

Scientific Presentations & Key Insights

Join the poster presentations featuring RetinAI Discovery^® platform and AI models, featuring new clinical data and proof-of-concept studies on AI-driven OCT analytics, trial candidate recruitment, and novel therapy monitoring.

‍